Joint and Several Guarantee Relating to Medical Device Development Outsourcing Fees
First written in FY2021-Q1. 11 of 12 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee for an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2025-H1RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2024-Q3RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2024-Q2RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル㈱ for an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2024-Q1RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million. - FY2023RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee for obligations under an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2023-Q2RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for obligations under an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2022-Q3RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for obligations under an outsourced research and development agreement related to medical device development. - FY2022-Q2RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee for obligations under an outsourced research and development agreement related to medical device development. - FY2022-Q1RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for obligations under an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2021-Q3RestatedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development.」
The company continues to disclose the joint and several guarantee provided by 不二ライトメタル株式会社 for obligations under an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million. - FY2021-Q1First statedAnnual report
「The consolidated subsidiary 不二ライトメタル㈱ provides a joint and several guarantee for obligations under an outsourced research and development agreement between 株式会社日本医療機器技研, which has entered into a comprehensive collaboration agreement for medical device development, and the Japan Agency for Medical Research and Development. Outsourcing expense cap: ¥1,350 million. Share of outsourcing expenses borne by 株式会社日本医療器技研: 100% if achievement of the outsourced research and development objectives is confirmed; 10% (¥135 million) if failure to achieve the objectives is confirmed.」
不二ライトメタル株式会社 provides a joint and several guarantee for obligations under an outsourced research and development agreement related to medical device development. The outsourcing expense cap is ¥1,350 million, and the amount borne if the objectives are not achieved is ¥135 million.